Determination of fluvoxamine in rat plasma by HPLC with pre-column derivatization and fluorescence detection using 4-fluoro-7-nitro-2,1,3-benzoxadiazole

Biomedical Chromatography

Volumn 19, Issue 10, 2005, Pages 771-776

  Higashi, Yasuhiko ^a   Matsumura, Hiroki ^a   Fujii, Youichi ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

4 fluoro 7 nitro 2,1,3 benzoxadiazole; Fluvoxamine; Pharmacokinetic study; Pre column derivatization

Indexed keywords

BODY FLUIDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHARMACOKINETICS;

4-FLUORO-7-NITRO-2,1,3-BENZOXADIAZOLE; FLUORESCENCE DETECTION; FLUVOXAMINE; PERFORMANCE; PHARMACOKINETIC STUDIES; PLASMA SAMPLES; PRE-COLUMN DERIVATISATION; RAT PLASMA; SENSITIVE METHOD; SIMPLE METHOD;

RATS;

AMITRIPTYLINE; AMOXAPINE; CARBAMAZEPINE; CLOMIPRAMINE; DESIPRAMINE; DROPERIDOL; ETHOSUXIMIDE; FLUOXETINE; FLUVOXAMINE MALEATE; HALOPERIDOL; IMIPRAMINE; MAPROTILINE; NORFLUOXETINE; NORTRIPTYLINE; PAROXETINE; PHENYTOIN; PRIMIDONE; PROPAFENONE; PROTRIPTYLINE; SERTRALINE; SPIPERONE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD VOLUME; CALIBRATION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG STABILITY; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; RELIABILITY; REPRODUCIBILITY;

ANIMALIA;

EID: 29544440518     PISSN: 02693879     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmc.514     Document Type: Article

References (25)

1. Aoyama C, Santa T, Tsunoda M, Fukushima T, Kitada C and Imai K. A fully automated amino acid analyzer using NBD-F as a fluorescent derivatization reagent. Biomedical Chromatography 2004: 18(9): 630-636.
2. Benfield P and Ward A. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1986; 32(4): 313-334.
3. Carrillo JA, Dahl ML, Svensson JO, Alm C, Rodriguez I and Bertilsson L. Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity. Clinical Pharmacological Therapy 1996; 60(2): 183-190.
4. Duverneuil C, de la Grandmaison GL, de Mazancourt P and Alvarez JC. A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs. Therapeutic Drug Monitoring 2003; 25(5): 565-573.
5. Eap CB, Gaillard N, Powell K and Baumann P. Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatography-mass spectrometry. Journal of Chromatography B 1996; 682(2): 265-272.
6. Foglia JP, Birder LA and Perel JM. Determination of fluvoxamine in human plasma by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography 1989; 495: 295-302.
7. Fukushima T, Kawai J, Imai K and Toyo'oka T. Simultaneous determination of D- and L-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection. Biomedical Chromatography 2004; 18(10): 813-819.
8. Guo X, Fukushima T, Li F and Imai K. Determination of fluoxetine and norfluoxetine in rat plasma by HPLC with pre-column derivatization and fluorescence detection. Biomedical Chromatography 2003; 17(1): 1-5.
9. Gupta RN. An improved solid phase extraction procedure for the determination of antidepressants in serum by column liquid chromatography. Journal of Liquid Chromatography 1993; 16(3): 2751-2765.
10. Hartter S, Wetzel H and Hiemke C. Automated determination of fluvoxamine in plasma by column-switching high-performance liquid chromatography. Clinical Chemistry 1992; 38(10): 2082-2086.
11. Honda S, Okeda J, Iwanaga H, Kawakami S, Taga A, Suzuki S and Imai K. Ultramicroanalysis of reducing carbohydrates by capillary electrophoresis with laser-induced fluorescence detection as 7-nitro-2,1,3-benzoxadiazole-tagged N-methylglycamine derivatives. Analytical Biochemistry 2000; 286(1): 99-111.
12. Imai K. Analytical chemical studies on high-performance recognition and detection of bio-molecules in life. Yakugaku Zasshi 2003; 123(11): 901-917.
13. Kent JM. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet 2000; 355(9207): 911-918.
14. Labat L, Deveaux M, Dallet P and Dubost JP. Separation of new antidepressants and their metabolites by micellar electrokinetic capillary chromatography. Journal of Chromatography B 2002; 773(1): 17-23.
15. Lacassie E, Gaulier JM, Marquet P, Rabatel JF and Lachatre G. Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography. Journal of Chromatography B 2000; 742(2): 229-238.
16. Lamas JP, Salgado-Petinal C, Garcia-Jares C, Llompart M, Cela R and Gomez M. Solid-phase microextraction-gas chromatography-mass spectrometry for the analysis of selective serotonin reuptake inhibitors in environmental water. Journal of Chromatography A 2004; 1046(1-2): 241-247.
17. Pommery J and Lhermitte M. High performance liquid chromatographic determination of fluvoxamine in human plasma. Biomedical Chromatography 1989; 3(4): 177-179.
18. Pullen RH and Fatmi AA. Determination of fluvoxamine in human plasma by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography 1992; 574(1): 101-107.
19. Spigset O, Carleborg L, Hedenmalm K and Dahlqvist R. Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans. Clinical Pharmacological Therapy 1995; 58(4): 399-403.
20. Suckow RF, Zhang MF and Cooper TB. Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization. Clinical Chemistry 1992; 38(9): 1756-1761.
21. Suzuki Y, Kawashima Y, Shioiri T and Someya T. Effects of concomitant fluvoxamine on the plasma concentration of etizolam in Japanese psychiatric patients: wide interindividual variation in the drug interaction. Therapeutic Drug Monitoring 2004; 26(6): 638-642.
22. Van der Meersch-Mougeot V and Diquet B. Sensitive one-step extraction procedure for column liquid chromatographic determination of fluvoxamine in human and rat plasma. Journal of Chromatography 1991; 567(2): 441-449.
23. Wakelin JS. Fluvoxamine in the treatment of the older depressed patient; double-blind, placebo-controlled data. International Clinical Psychopharmacology 1986; 1(3): 221-230.
24. Watanabe Y and Imai K. High-performance liquid chromatography and sensitive detection of amino acids derivatized with 7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole. Analytical Biochemistry 1981; 116(2): 471-472.
25. Watanabe Y and Imai K. Liquid chromatographic determination of amino and imino acids and thiols by postcolumn derivatization with 4-fluoro-7-nitrobenzo-2,1,3-oxadiazole. Analytical Chemistry 1983; 55(11): 1786-1791.